Again, you make two claims here. 1: co-pays for Daraprim are very high. 2. Turing does not reimburse for those high co-pays.<p>You&#x27;re right about number 1.<p>You cite no evidence for number 2. For its part, Turing says they reimburse for the high co-pays. Why wouldn&#x27;t they? It would be a PR disaster not to reimburse, so it&#x27;s manifestly in their interest. And they&#x27;re making such a fat profit they can afford to reimburse people for high co-pays.<p>Page 4 of the document you cited is just a list of examples of high co-pays. Yes.<p>Again, where&#x27;s the evidence that Turing does NOT reimburse for those co-pays? Do you have an example?